In vitro and in vivo effects of fulvestrant combined with trastuzumab in breast cancer with estrogen receptor-positive and HER-2/neu-overexpressing

被引：0
|
作者：
Chen, Q. [1 ]
Wu, K. [1 ]
Lu, Y. [1 ]
Ding, L. [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Gen Surg, Shanghai 200030, Peoples R China
来源：
EUROPEAN JOURNAL OF CANCER | 2016年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
421
引用
收藏
页码：S121 / S122
页数：2
相关论文
共 50 条
  • [11] Amplification of Her-2/neu in Her-2/neu-overexpressing breast cancers and in associated synchronous benign and malignant lesions.
    Xu, R
    Feiner, H
    Inghirami, G
    Chan, W
    Delgado, Y
    Perle, MA
    MODERN PATHOLOGY, 2001, 14 (01) : 42A - 42A
  • [12] Combination therapy of Ad-mda7 and trastuzumab increases cell death in Her-2/neu-overexpressing breast cancer cells
    McKenzie, T
    Liu, Y
    Fanale, M
    Swisher, SG
    Chada, S
    Hunt, KK
    SURGERY, 2004, 136 (02) : 437 - 442
  • [13] Functional assay for HER-2/neu demonstrates active signalling in a minority of HER-2/neu-overexpressing invasive human breast tumours
    DiGiovanna, MP
    Carter, D
    Flynn, SD
    Stern, DF
    BRITISH JOURNAL OF CANCER, 1996, 74 (05) : 802 - 806
  • [14] Adjuvant therapy with trastuzumab for HER-2/neu-positive breast cancer
    Gonzalez-Angulo, Ana M.
    Hortobagyi, Gabriel N.
    Esteva, Francisco J.
    ONCOLOGIST, 2006, 11 (08): : 857 - 867
  • [15] No changes in chemosensitivity to lidamycin in HER-2/neu-overexpressing breast cancer MCF-7 cells
    Shi, YK
    Zhen, YS
    ONCOLOGY RESEARCH, 2006, 15 (10-12) : 475 - 475
  • [16] Toward customized trastuzumab in HER-2/neu-overexpressing non-small-cell lung cancers
    Rosell, R
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (07) : 1171 - 1173
  • [17] Proteomic characterization of Her2/neu-overexpressing breast cancer cells
    Chen, Hexin
    Pimienta, Genaro
    Gu, Yiben
    Sun, Xu
    Hu, Jianjun
    Kim, Min-Sik
    Chaerkady, Raghothama
    Gucek, Marjan
    Cole, Robert N.
    Sukumar, Saraswati
    Pandey, Akhilesh
    PROTEOMICS, 2010, 10 (21) : 3800 - 3810
  • [18] Trastuzumab plus gemcitabine and cisplatin chemotherapy for HER2/neu-overexpressing breast cancer with visceral metastasis
    Elsaid, A. A.
    Elkerm, Y.
    El-Shami, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [19] ECONOMIC EVALUATION OF ADJUVANT TRASTUZUMAB IN THE TREATMENT OF EARLY, HER2/NEU-OVEREXPRESSING BREAST CANCER IN SINGAPORE
    Lopes, G. De Lima
    EJC SUPPLEMENTS, 2011, 9 (01): : 8 - 8
  • [20] HER-2/neu and p53 expression versus tamoxifen resistance in estrogen receptor-positive, node-positive breast cancer
    Berry, DA
    Muss, HB
    Thor, AD
    Dressler, L
    Liu, ET
    Broadwater, G
    Budman, DR
    Henderson, IC
    Barcos, M
    Hayes, D
    Norton, L
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (20) : 3471 - 3479
12345